Search

everythinglearnresearchcommunity

for

Search:↓

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Male hair loss is mainly due to thinner hair, not less hair.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

A woman's hair loss was likely caused by a cream used for skin treatment and improved after she stopped using it.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Scalp reduction surgery is safe and effective for certain patients with hair loss, leading to dense hair coverage and high satisfaction.

The book is a detailed guide on hair replacement surgery and its practices.

Female pattern hair loss in women is caused by hormones and genetics, leading to hair thinning, with various treatments available.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

Caffeine may help with hair loss, but more research is needed.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.

Targeting DNA methylation can help treat skin disorders and cancers.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Cicatricial alopecia can progress to complete hair loss, making diagnosis and management difficult.

Hairless mice lose hair by 3-4 weeks, develop thicker, folded skin, and show pigmentation differences.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Most children with pediatric trachyonychia improve over time, regardless of treatment.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Early diagnosis and treatment of hair loss in children are crucial to prevent permanent damage.